Use of Individual Components and Advances in Topical Formulation Technology: Focus on Corticosteroids

Article Type
Article
Changed
Thu, 01/10/2019 - 12:44
Display Headline
Use of Individual Components and Advances in Topical Formulation Technology: Focus on Corticosteroids
Author(s)
Del Rosso Jq

Article PDF
019110677.pdf
Author and Disclosure Information

Del Rosso JQ

Issue
Cutis - 78(5)
Publications
Cutis
MDedge Dermatology
Topics
Aesthetic Dermatology
Page Number
677-680
Sections
From the Cosmetic Dermatology Archives
Author(s)
Del Rosso Jq
Author(s)
Del Rosso Jq
Author and Disclosure Information

Del Rosso JQ

Author and Disclosure Information

Del Rosso JQ

Article PDF
019110677.pdf
Article PDF
019110677.pdf

Issue
Cutis - 78(5)
Issue
Cutis - 78(5)
Page Number
677-680
Page Number
677-680
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Aesthetic Dermatology
Article Type
Article
Display Headline
Use of Individual Components and Advances in Topical Formulation Technology: Focus on Corticosteroids
Display Headline
Use of Individual Components and Advances in Topical Formulation Technology: Focus on Corticosteroids
Sections
From the Cosmetic Dermatology Archives
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

Chemical Stability and Tolerability of Topical Benzoyl Peroxide 5%/Clindamycin 1% Gel in Combination With Topical Retinoids and Sunscreens

Article Type
Article
Changed
Thu, 01/10/2019 - 12:44
Display Headline
Chemical Stability and Tolerability of Topical Benzoyl Peroxide 5%/Clindamycin 1% Gel in Combination With Topical Retinoids and Sunscreens
Author(s)
Del Rosso Jq

Article PDF
019080513.pdf
Author and Disclosure Information

Del Rosso JQ

Issue
Cutis - 78(2)
Publications
Cutis
MDedge Dermatology
Topics
Acne
Aesthetic Dermatology
Page Number
513-516
Sections
From the Cosmetic Dermatology Archives
Author(s)
Del Rosso Jq
Author(s)
Del Rosso Jq
Author and Disclosure Information

Del Rosso JQ

Author and Disclosure Information

Del Rosso JQ

Article PDF
019080513.pdf
Article PDF
019080513.pdf

Issue
Cutis - 78(2)
Issue
Cutis - 78(2)
Page Number
513-516
Page Number
513-516
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Acne
Aesthetic Dermatology
Article Type
Article
Display Headline
Chemical Stability and Tolerability of Topical Benzoyl Peroxide 5%/Clindamycin 1% Gel in Combination With Topical Retinoids and Sunscreens
Display Headline
Chemical Stability and Tolerability of Topical Benzoyl Peroxide 5%/Clindamycin 1% Gel in Combination With Topical Retinoids and Sunscreens
Sections
From the Cosmetic Dermatology Archives
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

Defining Criteria Used to Evaluate Response to Treatment of Acne Vulgaris

Article Type
Article
Changed
Thu, 01/10/2019 - 12:08
Display Headline
Defining Criteria Used to Evaluate Response to Treatment of Acne Vulgaris
Author(s)
Del Rosso Jq

Article PDF
078020117.pdf
Author and Disclosure Information

Del Rosso JQ

Issue
Cutis - 78(2)
Publications
Cutis
MDedge Dermatology
Topics
Acne
Page Number
117-121
Author(s)
Del Rosso Jq
Author(s)
Del Rosso Jq
Author and Disclosure Information

Del Rosso JQ

Author and Disclosure Information

Del Rosso JQ

Article PDF
078020117.pdf
Article PDF
078020117.pdf

Issue
Cutis - 78(2)
Issue
Cutis - 78(2)
Page Number
117-121
Page Number
117-121
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Acne
Article Type
Article
Display Headline
Defining Criteria Used to Evaluate Response to Treatment of Acne Vulgaris
Display Headline
Defining Criteria Used to Evaluate Response to Treatment of Acne Vulgaris
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Update on Rosacea Pathogenesis and Correlation With Medical Therapeutic Agents

Article Type
Article
Changed
Thu, 01/10/2019 - 12:08
Display Headline
Update on Rosacea Pathogenesis and Correlation With Medical Therapeutic Agents
Author(s)
Del Rosso Jq

Article PDF
078020097.pdf
Author and Disclosure Information

Del Rosso JQ

Issue
Cutis - 78(2)
Publications
Cutis
MDedge Dermatology
Topics
Rosacea
Page Number
97-100
Sections
Drug Therapy
Author(s)
Del Rosso Jq
Author(s)
Del Rosso Jq
Author and Disclosure Information

Del Rosso JQ

Author and Disclosure Information

Del Rosso JQ

Article PDF
078020097.pdf
Article PDF
078020097.pdf

Issue
Cutis - 78(2)
Issue
Cutis - 78(2)
Page Number
97-100
Page Number
97-100
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Rosacea
Article Type
Article
Display Headline
Update on Rosacea Pathogenesis and Correlation With Medical Therapeutic Agents
Display Headline
Update on Rosacea Pathogenesis and Correlation With Medical Therapeutic Agents
Sections
Drug Therapy
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Management of Truncal Acne Vulgaris: Current Perspectives on Treatment

Article Type
Article
Changed
Thu, 01/10/2019 - 12:07
Display Headline
Management of Truncal Acne Vulgaris: Current Perspectives on Treatment
Author(s)
Del Rosso Jq

Article PDF
077050285.pdf
Author and Disclosure Information

Del Rosso JQ

Issue
Cutis - 77(5)
Publications
Cutis
MDedge Dermatology
Topics
Acne
Page Number
285-289
Sections
Drug Therapy
Author(s)
Del Rosso Jq
Author(s)
Del Rosso Jq
Author and Disclosure Information

Del Rosso JQ

Author and Disclosure Information

Del Rosso JQ

Article PDF
077050285.pdf
Article PDF
077050285.pdf

Issue
Cutis - 77(5)
Issue
Cutis - 77(5)
Page Number
285-289
Page Number
285-289
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Acne
Article Type
Article
Display Headline
Management of Truncal Acne Vulgaris: Current Perspectives on Treatment
Display Headline
Management of Truncal Acne Vulgaris: Current Perspectives on Treatment
Sections
Drug Therapy
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Clinical Significance of Brand Versus Generic Formulations: Focus on Oral Minocycline

Article Type
Article
Changed
Thu, 01/10/2019 - 12:07
Display Headline
Clinical Significance of Brand Versus Generic Formulations: Focus on Oral Minocycline
Author(s)
Del Rosso Jq

Article PDF
077030153.pdf
Author and Disclosure Information

Del Rosso JQ

Issue
Cutis - 77(3)
Publications
Cutis
MDedge Dermatology
Page Number
153-157
Sections
Drug Therapy
Author(s)
Del Rosso Jq
Author(s)
Del Rosso Jq
Author and Disclosure Information

Del Rosso JQ

Author and Disclosure Information

Del Rosso JQ

Article PDF
077030153.pdf
Article PDF
077030153.pdf

Issue
Cutis - 77(3)
Issue
Cutis - 77(3)
Page Number
153-157
Page Number
153-157
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Article Type
Article
Display Headline
Clinical Significance of Brand Versus Generic Formulations: Focus on Oral Minocycline
Display Headline
Clinical Significance of Brand Versus Generic Formulations: Focus on Oral Minocycline
Sections
Drug Therapy
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

The Use of Topical Imiquimod for the Treatment of Actinic Keratosis: A Status Report

Article Type
Article
Changed
Thu, 01/10/2019 - 12:05
Display Headline
The Use of Topical Imiquimod for the Treatment of Actinic Keratosis: A Status Report
Author(s)
Del Rosso Jq

Article PDF
076040241.pdf
Author and Disclosure Information

Del Rosso JQ

Issue
Cutis - 76(4)
Publications
Cutis
MDedge Dermatology
Topics
Actinic Keratosis
Nonmelanoma Skin Cancer
Page Number
241-248
Sections
Drug Therapy
Author(s)
Del Rosso Jq
Author(s)
Del Rosso Jq
Author and Disclosure Information

Del Rosso JQ

Author and Disclosure Information

Del Rosso JQ

Article PDF
076040241.pdf
Article PDF
076040241.pdf

Issue
Cutis - 76(4)
Issue
Cutis - 76(4)
Page Number
241-248
Page Number
241-248
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Actinic Keratosis
Nonmelanoma Skin Cancer
Article Type
Article
Display Headline
The Use of Topical Imiquimod for the Treatment of Actinic Keratosis: A Status Report
Display Headline
The Use of Topical Imiquimod for the Treatment of Actinic Keratosis: A Status Report
Sections
Drug Therapy
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

A Qualitative and Quantitative Assessment of the Application and Use of Topical Acne Medication by Patients

Article Type
Article
Changed
Thu, 01/10/2019 - 12:05
Display Headline
A Qualitative and Quantitative Assessment of the Application and Use of Topical Acne Medication by Patients
Author(s)
Del Rosso Jq

Article PDF
076020109.pdf
Author and Disclosure Information

Del Rosso JQ

Issue
Cutis - 76(2)
Publications
Cutis
MDedge Dermatology
Topics
Acne
Page Number
109-113
Sections
Drug Therapy
Author(s)
Del Rosso Jq
Author(s)
Del Rosso Jq
Author and Disclosure Information

Del Rosso JQ

Author and Disclosure Information

Del Rosso JQ

Article PDF
076020109.pdf
Article PDF
076020109.pdf

Issue
Cutis - 76(2)
Issue
Cutis - 76(2)
Page Number
109-113
Page Number
109-113
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Acne
Article Type
Article
Display Headline
A Qualitative and Quantitative Assessment of the Application and Use of Topical Acne Medication by Patients
Display Headline
A Qualitative and Quantitative Assessment of the Application and Use of Topical Acne Medication by Patients
Sections
Drug Therapy
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

A Status Report on the Use of Subantimicrobial-Dose Doxycycline: A Review of the Biologic and Antimicrobial Effects of the Tetracyclines

Article Type
Article
Changed
Thu, 01/10/2019 - 12:02
Display Headline
A Status Report on the Use of Subantimicrobial-Dose Doxycycline: A Review of the Biologic and Antimicrobial Effects of the Tetracyclines
Author(s)
Del Rosso Jq

Article PDF
074020118.pdf
Author and Disclosure Information

Del Rosso JQ

Issue
Cutis - 74(2)
Publications
Cutis
MDedge Dermatology
Topics
Acne
Rosacea
Page Number
118-122
Sections
Drug Therapy
Author(s)
Del Rosso Jq
Author(s)
Del Rosso Jq
Author and Disclosure Information

Del Rosso JQ

Author and Disclosure Information

Del Rosso JQ

Article PDF
074020118.pdf
Article PDF
074020118.pdf

Issue
Cutis - 74(2)
Issue
Cutis - 74(2)
Page Number
118-122
Page Number
118-122
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Acne
Rosacea
Article Type
Article
Display Headline
A Status Report on the Use of Subantimicrobial-Dose Doxycycline: A Review of the Biologic and Antimicrobial Effects of the Tetracyclines
Display Headline
A Status Report on the Use of Subantimicrobial-Dose Doxycycline: A Review of the Biologic and Antimicrobial Effects of the Tetracyclines
Sections
Drug Therapy
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

New and Emerging Topical Approaches for Actinic Keratoses

Article Type
Article
Changed
Thu, 01/10/2019 - 11:59
Display Headline
New and Emerging Topical Approaches for Actinic Keratoses
Author(s)
Del Rosso Jq

Article PDF
072040273.pdf
Author and Disclosure Information

James Q. Del Rosso, DO

Accepted for publication August 20, 2003. From the Department of Dermatology, University of Nevada School of Medicine, Las Vegas.
Dr. Del Rosso has served as either a consultant or speaker, or both, for 3M Pharmaceuticals; Allergan, Inc; Berlex Laboratories; Bristol-Myers Squibb Company; Connetics Corporation; Dermik Laboratories, Inc; Galderma Laboratories, LP; GlaxoSmithKline; Healthpoint, Ltd; Janssen Pharmaceutica Products, LP; Medicis, The Dermatology Company; Novartis Pharmaceuticals Corporation; and Ortho Neutrogena.

Issue
Cutis - 72(4)
Publications
Cutis
MDedge Dermatology
Page Number
273-276
Sections
Drug Therapy
Author(s)
Del Rosso Jq
Author(s)
Del Rosso Jq
Author and Disclosure Information

James Q. Del Rosso, DO

Accepted for publication August 20, 2003. From the Department of Dermatology, University of Nevada School of Medicine, Las Vegas.
Dr. Del Rosso has served as either a consultant or speaker, or both, for 3M Pharmaceuticals; Allergan, Inc; Berlex Laboratories; Bristol-Myers Squibb Company; Connetics Corporation; Dermik Laboratories, Inc; Galderma Laboratories, LP; GlaxoSmithKline; Healthpoint, Ltd; Janssen Pharmaceutica Products, LP; Medicis, The Dermatology Company; Novartis Pharmaceuticals Corporation; and Ortho Neutrogena.

Author and Disclosure Information

James Q. Del Rosso, DO

Accepted for publication August 20, 2003. From the Department of Dermatology, University of Nevada School of Medicine, Las Vegas.
Dr. Del Rosso has served as either a consultant or speaker, or both, for 3M Pharmaceuticals; Allergan, Inc; Berlex Laboratories; Bristol-Myers Squibb Company; Connetics Corporation; Dermik Laboratories, Inc; Galderma Laboratories, LP; GlaxoSmithKline; Healthpoint, Ltd; Janssen Pharmaceutica Products, LP; Medicis, The Dermatology Company; Novartis Pharmaceuticals Corporation; and Ortho Neutrogena.

Article PDF
072040273.pdf
Article PDF
072040273.pdf

Issue
Cutis - 72(4)
Issue
Cutis - 72(4)
Page Number
273-276
Page Number
273-276
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Article Type
Article
Display Headline
New and Emerging Topical Approaches for Actinic Keratoses
Display Headline
New and Emerging Topical Approaches for Actinic Keratoses
Sections
Drug Therapy
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Del Rosso Jq